PL EN


Preferences help
enabled [disable] Abstract
Number of results
2015 | 62 | 2 | 241-245
Article title

Association between UBE2E2 variant rs7612463 and type 2 diabetes mellitus in a Chinese Han Population

Content
Title variants
Languages of publication
EN
Abstracts
EN
UBE2E2 encodes ubiquitin-conjugating enzyme E2E2, which plays an important role in the synthesis and secretion of insulin. Two previous studies indicated that SNPs in UBE2E2 were associated with risk for type 2 diabetes mellitus (T2DM) in the Japanese and Korean populations, respectively. We examined the association of one SNP in this gene, rs7612463, with the risk of T2DM in 1957 Han participants in northeastern China, using an SNPscanTM Kit. rs7612463 genotype was significantly associated with risk for T2DM under various genetic models, including an additive model (P = 0.004), a dominant model (P = 0.024), and a recessive model (P = 0.008). The AA genotype was associated with a significantly decreased risk for T2DM (P = 0.004, OR = 0.513, 95% CI = 0.325-0.810) after adjustment for age, gender, and BMI. The heterozygous genotype, AC, was associated with increased risk for total cholesterol (mmol l-1; P = 0.031) and triglycerides (mmol l-1; P = 0.039) in control individuals. Our results show that rs7612463 is associated with T2DM, with homozygotes of the AA genotype at decreased risk for T2DM in the Chinese population. Additionally, heterozygotes may have decreased risk of T2DM due to insulin resistance.
Publisher

Year
Volume
62
Issue
2
Pages
241-245
Physical description
Dates
published
2015
received
2014-11-13
revised
2015-04-12
accepted
2015-04-18
(unknown)
2015-05-28
Contributors
  • Department of Endemic Disease, the Second Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang, China
author
  • Department of Endemic Disease, the Second Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang, China
author
  • Department of Endemic Disease, the Second Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang, China
author
  • Department of Endemic Disease, the Second Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang, China
author
  • Department of Endemic Disease, the Second Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang, China
author
  • Department of Endemic Disease, the Second Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang, China
  • Department of Endemic Disease, the Second Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang, China
author
  • Department of Endemic Disease, the Second Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang, China
author
  • Department of Endemic Disease, the Second Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang, China
References
  • Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15: 539-553.
  • Alberti KG, Zimmet P, Shaw J (2006) Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International. Diabet Med 23: 469-480.
  • Alharbi KK, Khan IA, Al-Sheikh YA, Alharbi FK, Alharbi FK, Al-Nbaheen MS (2014) Lack of association between UBE2E2 gene polymorphism (rs7612463) and type 2 diabetes mellitus in a Saudi population. Acta Biochim Pol 61: 769-772.
  • Balasubramanyam M, Sampathkumar R, Mohan V (2005) Is insulin signaling molecules misguided in diabetes for ubiquitin-proteasome mediated degradation? Mol Cell Biochem 275: 117-125.
  • Chang TL, Chang CJ, Lee WY, Lin MN, Huang YW, Fan K (2009) The roles of ubiquitin and 26S proteasome in human obesity. Metabolism 58: 1643-1648.
  • Criqui MH, Heiss G, Cohn R, Cowan LD, Suchindran CM, Bangdiwala S, Kritchevsky S, Jacobs DR, O'Grady HK, Davis CE (1993) Plasma triglyceride level and mortality from coronary heart disease. N Engl J Med 328: 1220-1225.
  • Dmitriev AA, Kashuba VI, Haraldson K, Senchenko VN, Pavlova TV, Kudryavtseva AV, Anedchenko EA, Krasnov GS, Pronina IV, Loginov VI, Kondratieva TT, Kazubskaya TP, Braga EA, Yenamandra SP, Ignatjev I, Ernberg I, Klein G, Lerman MI, Zabarovsky ER (2012) Genetic and epigenetic analysis of non-small cell lung cancer with NotI-microarrays. Epigenetics 7: 502-513.
  • Hartley T, Brumel J, Volchuk A (2009) Emerging roles for the ubiquitin-proteasome system and autophagy in pancreatic β-cells. Am J Physiol Endocrinol Metab 296: E1-E10.
  • Hicke L (1999) Gettin' down with ubiquitin: turning off cell-surface receptors, transporters and channels. Trends Cell Biol 9: 107-112.
  • Iwata M, Maeda S, Kamura Y, Takano A, Kato H, Murakami S, Higuchi K, Takahashi A, Fujita H, Hara K, Kadowaki T, Tobe K (2012) Genetic risk score constructed using 14 susceptibility alleles for type 2 diabetes is associated with the early onset of diabetes and may predict the future requirement of insulin injections among Japanese individuals. Diabetes Care 35: 1763-1770.
  • Jentsch S (1992) The ubiquitin-conjugation system. Annu Rev Genet 26: 179-207.
  • Laakso M, Lehto S, Penttilä I, Pyörälä K (1993) Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent. Circulation 88: 1421-1430.
  • Manninen V, Tenkanen L, Koskinen P, Huttunen JK, Mänttäri M, Heinonen OP, Frick MH (1992) Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Circulation 85: 37-45.
  • Marfella R, D'Amico M, Esposito K, Baldi A, Di Filippo C, Siniscalchi M, Sasso FC, Portoghese M, Cirillo F, Cacciapuoti F, Carbonara O, Crescenzi B, Baldi F, Ceriello, Nicoletti GF, D'Andrea F, Verza M, Coppola L, Rossi F, Giugliano D (2006) The ubiquitin-proteasome system and inflammatory activity in diabetic atherosclerotic plaques: effects of rosiglitazone treatment. Diabetes 55: 622-632.
  • Park KS (2011) The Search for genetic risk factors of type 2 diabetes mellitus. Diabetes Metab J 35: 12-22.
  • Saltie AR, Kahn CR (2001) Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414: 799-806.
  • Sanghera DK, Blackett PR (2012) Type 2 Diabetes Genetics: Beyond GWAS. J Diabetes Metab 3 6948.
  • Strous GJ, Govers R. (1999) The ubiquitin-proteasome system and endocytosis. J Cell Sci 112: 1417-1423.
  • Stumvoll M, Goldstein BJ, van Haeften TW (2005) Type 2 diabetes: principles of pathogenesis and therapy. Lancet 365: 1333-1346.
  • Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047-1053.
  • Yamauchi T, Hara K, Maeda S, Yasuda K, Takahashi A, Horikoshi M, Nakamura M, Fujita H, Grarup N, Cauchi S, Tsunoda T, Kubo M, Witte H, Jørgensen T, Lauritzen T, Sandbæk A, Hansen T, Ohshige T, Omori S, Saito I, Kaku K, Hirose H, So MY, Beury D, Chan J, Park KS, Tai,ES, Ito C, Tanaka Y, KashiwagiA, Kawamori R, Kasuga M, Froguel P, Pedersen O, Kamatani N, Nakamura Y, Kadowaki T (2010) A genome-wide association study in the Japanese population identifies susceptibility loci for type 2 diabetes at UBE2E2 and C2CD4A-C2CD4B. Nat Genet 42: 864-868.
Document Type
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.bwnjournal-article-abpv62p241kz
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.